Bilirubin
Cytochrome C
Gastric Mucin
HCG
FSH
UTI
PMSG
Aprotinin
Asparaginase
Beta Glucanase
Bromelain
Chymotrypsin
Kallikrein
Lysozyme
Pancreatin
Papain
Pepsin
Streptokinase
Trypsin
Urokinase
Coenzyme A
Coenzyme A Trilithium
Coenzyme Q10
Beta Glucans
Chitosan
Chondroitin Sulfate
Dextran
Dextran Sulfate Sodium
Glucosamine HCl
Heparin Sodium
Heparinoid
Hyaluronic Acid
Rosemary Extract
Sodium Cholate
Bilirubin
Cytochrome C
Gastric Mucin
HCG
FSH
UTI
PMSG
Aprotinin
Asparaginase
Beta Glucanase
Bromelain
Chymotrypsin
Kallikrein
Lysozyme
Pancreatin
Papain
Pepsin
Streptokinase
Trypsin
Urokinase
Coenzyme A
Coenzyme A Trilithium
Coenzyme Q10
Beta Glucans
Chitosan
Chondroitin Sulfate
Dextran
Dextran Sulfate Sodium
Glucosamine HCl
Heparin Sodium
Heparinoid
Hyaluronic Acid
Rosemary Extract
Sodium Cholate
Jiagen Biotechnologies
Enzymes

Pancreatin

CAS No:8049-47-6
EINECS No:232-469-9
Synonyms:Pancreatic enzymes, pancreatic extract, pancreatin from porcine pancreas, pancreatin from hog pancreas

Product Summary

Pancreatin is a mixture of digestive enzymes extracted primarily from porcine or bovine pancreas. It contains key enzyme components such as amylase, lipase and proteases (e.g., trypsin, chymotrypsin). Pancreatin is a broad-spectrum enzymatic blend mimicking natural pancreatic secretions. It is widely used for its digestive properties, with proven applications in medicine, food processing, and biological research. Its multi-enzyme composition and predictable enzymatic profile make it essential in treating pancreatic disorders and in simulating digestion systems in research.

Biochemical Function & Mechanism of Action

The function of pacreatin mimics natural pancreatic secretions, aiding in digestion and absorption of nutrients in gastrointestinal tract. Pancreatin acts in the duodenum and small intestine, where:

  • Amylase hydrolyzes starch into maltose and dextrins.
  • Lipase catalyzes the breakdown of triglycerides into fatty acids and glycerol.
  • Proteases cleave proteins into smaller peptides and amino acids.

This enzymatic activity enhances nutrient availability for absorption, especially in individuals with pancreatic insufficiency.

Applications in Scientific Research

  • Exocrine pancreatic insufficiency (EPI) models: Used to simulate or supplement deficient pancreatic enzyme activity in studies on cystic fibrosis, chronic pancreatitis, and post-surgical malabsorption.
  • Dissolution testing: Pancreatin mimics intestinal conditions to assess drug release profiles, particularly for lipid-based formulations.
  • Nutrient absorption studies: Used to evaluate digestibility of proteins, fats, and carbohydrates in enteral nutrition and food science research.
  • Pancreatic cancer metastasis: Studies on cholesterol metabolism (e.g., PCSK9 protein’s role in liver/lung metastasis) use pancreatin to digest tumor microenvironments for analysis.

Packaging & Storage

  • Available as white to slightly yellow amorphous powder.
  • Store in an airtight container at 4-8°C.

References

  1. Liu X. 2022: The positive effects of exogenous pancreatin on growth performance, nutrient digestion and absorption, and intestinal microbiota in piglets, Front Physiol. 13:906522.
  2. Andriamihaja M, et al. 2013: Comparative efficiency of microbial enzyme preparations versus pancreatin for in vitro alimentary protein digestion, Amino Acids. 44(2):563-72.
  3. Chang CT, et al. 1985: Preparation of pancreatin and purification of lipase from hog pancreas, Proc Natl Sci Counc Repub China B. 9(2):75-81.
  4. Terra GDP, et al. 2016: Evaluation of pancreatin stability through enzyme activity determination, Acta Pharm. 66(3):423-31.
  5. Lohr JM, et al. 2009: Properties of different pancreatin preparations used in pancreatic exocrine insufficiency, Eur J Gastroenterol Hepatol. 21(9):1024-31.
  6. Maev IV, et al. 2020: Differences in in vitro properties of pancreatin preparations for pancreatic exocrine insufficiency as marketed in Russia and CIS, Drugs R D. 20(4):369-76.
  7. Aloulou A, et al. 2008: In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability, Aliment Pharmacol Ther. 27(3):283-92.
  8. Mössner J, Keim V. 2021: Pancreatic enzyme therapy, Dtsch Arztebl Int. 108(34-35):578–82.
  9. Thorat V, et al. 2012: Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study, Aliment Pharmacol Ther. 36(5):426-36.
  10. Suarez F, et al. 1999: Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal, Dig Dis Sci. 44(7):1317-21.
  11. Saruc M, et al. 2004: Pancreatic enzyme extract improves survival in murine pancreatic cancer, Pancreas. 28(4):401-12.
  12. Delchi L, et al. 1971: Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two pancreatic enzyme preparations, Aliment Pharmacol Ther. 5(4):365-78.

Jiagen Biotechnologies supplies quality Pancreatin of various specifications.
Contact us at sales@jiagen.ca to place an order.

Order